A targeting ligand enhances infectivity and cytotoxicity of an oncolytic adenovirus in human pancreatic cancer tissues

被引：0
|
作者：
Yamamoto, Yuki [1 ,3 ]
Hiraoka, Nobuyoshi [2 ]
Goto, Naoko [1 ]
Rin, Yosei [1 ,3 ]
Miura, Kazuki [1 ,3 ]
Narumi, Kenta [1 ]
Uchida, Hiroaki [3 ]
Tagawa, Masatoshi [4 ]
Aoki, Kazunori [1 ]
机构：
[1] Division of Gene and Immune Medicine, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo,104-0045, Japan
[2] Division of Molecular Pathology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo,104-0045, Japan
[3] Laboratory of Oncology, Tokyo University of Pharmacy and Life Sciences, 432-1 Horinouchi, Hachioji, Tokyo,192-0355, Japan
[4] Division of Pathology and Cell Therapy, Chiba Cancer Center Research Institute, 666-2 Nitona-chou, Chuo-ku, Chiba,260-0801, Japan
来源：
Journal of Controlled Release | 2014年 / 192卷
关键词：
Compendex;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Cancer cells
引用
下载
收藏
页码：284 / 293
相关论文
共 50 条
  • [41] Intravenous Application of Mesothelin-targeted Oncolytic Adenovirus in Pancreatic Cancer
    Sato-Dahlman, M.
    Miura, Y.
    Hajeri, P.
    Yoshida, H.
    Jacobsen, K.
    Yanagiba, C.
    Yamamoto, M.
    PANCREAS, 2019, 48 (10) : 1516 - 1516
  • [42] IFN Expressing Oncolytic Adenovirus as a Tool to Improve Pancreatic Cancer Therapy
    Salzwedel, Amanda Oliveira
    Shanley, Ryan
    Davydova, Julia
    Yamamoto, Masato
    FASEB JOURNAL, 2019, 33
  • [43] Intravenous Application of Mesothelin-Targeted Oncolytic Adenovirus to Pancreatic Cancer
    Sato-Dahlman, Mizuho
    Miura, Yoshiaki
    Hajeri, Praveensingh
    Yoshida, Hideki
    Jacobsen, Kari
    Yanagiba, Chikako
    Yamamoto, Masato
    MOLECULAR THERAPY, 2019, 27 (04) : 124 - 124
  • [44] Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors
    Yamamoto, Yuki
    Nagasato, Masaki
    Rin, Yosei
    Henmi, Marina
    Ino, Yoshinori
    Yachida, Shinichi
    Ohki, Rieko
    Hiraoka, Nobuyoshi
    Tagawa, Masatoshi
    Aoki, Kazunori
    CANCER MEDICINE, 2017, 6 (10): : 2385 - 2397
  • [45] Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model
    Chu, Quyen D.
    Sun, Guang
    Pope, Matt
    Luraguiz, Natalia
    Curiel, David T.
    Kim, Roger
    Li, Benjamin D. L.
    Mathis, J. Michael
    SURGERY, 2012, 152 (03) : 441 - 448
  • [46] A dopamine antagonist, domperidone enhances the replication of an oncolytic adenovirus in human tumour cells
    Nishimae, Fumitaka
    Sakurai, Fuminori
    Ono, Ryosuke
    Onishi, Rika
    Takayama, Kosuke
    Mizuguchi, Hiroyuki
    JOURNAL OF GENERAL VIROLOGY, 2022, 103 (06):
  • [47] Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus
    Kaliberov, S. A.
    Kaliberova, L. N.
    Buchsbaum, D. J.
    Curiel, D. T.
    CANCER GENE THERAPY, 2014, 21 (07) : 264 - 274
  • [48] Experimental virotherapy of chemoresistant pancreatic carcinoma using infectivity-enhanced fiber-mosaic oncolytic adenovirus
    S A Kaliberov
    L N Kaliberova
    D J Buchsbaum
    D T Curiel
    Cancer Gene Therapy, 2014, 21 : 264 - 274
  • [49] Targeting Telomerase Enhances Cytotoxicity of Salinomycin in Cancer Cells
    Qin, Hongshuang
    Guo, Yanxiang
    ACS OMEGA, 2022, : 30565 - 30570
  • [50] An oncolytic virus targeting desmoplasia and immune activation in pancreatic cancer
    Eriksson, Emma
    Milenova, Ioanna
    Wenthe, Jessica
    Moreno, Rafael
    Alemany, Ramon
    Loskog, Angelica
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2017, 86 (04) : 335 - 335
12345